Spero Therapeutics Inc. logo

Spero Therapeutics Inc. (SPRO)

Market Closed
18 Aug, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
1. 20
+0.01
+0.8403%
$
71.8M Market Cap
3.69 P/E Ratio
- Div Yield
475,676 Volume
-0.52 Eps
$ 1.19
Previous Close
Add Transaction
Day Range
1.18 1.2
Year Range
1.08 3.08
Want to track SPRO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Spero Therapeutics Inc. logo
SPRO Spero Therapeutics Inc.
11 May 2026
-
-
Spero Therapeutics Inc. logo
SPRO Spero Therapeutics Inc.
26 Mar 2026
-
-
Spero Therapeutics Inc. logo
SPRO Spero Therapeutics Inc.
17 Nov 2025
-
-
Spero Therapeutics Inc. logo
SPRO Spero Therapeutics Inc.
7 Aug 2025
-
-
Spero Therapeutics Inc. logo
SPRO Spero Therapeutics Inc.
13 May 2025
-
-
Spero Therapeutics Inc. logo
SPRO Spero Therapeutics Inc.
11 Mar 2025
-
-
Spero Therapeutics Inc. logo
SPRO Spero Therapeutics Inc.
11 Nov 2024
-
-
Spero Therapeutics Inc. logo
SPRO Spero Therapeutics Inc.
8 Aug 2024
-
-
Spero Therapeutics Inc. logo
SPRO Spero Therapeutics Inc.
9 May 2024
-
-
Spero Therapeutics Inc. logo
SPRO Spero Therapeutics Inc.
13 Mar 2024
-
0.96
Spero Therapeutics Inc. logo
SPRO Spero Therapeutics Inc.
13 Nov 2023
-
0.04

SPRO Earnings Reports FAQ

What is the earnings per share (EPS) for SPRO?

The current EPS is -0.52.

What is the company's earnings growth rate?

Spero Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Spero Therapeutics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Spero Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for SPRO at this time, as Spero Therapeutics Inc has no recent EPS data to calculate it.